Inflammation and colorectal cancer: colitis-associated neoplasia (original) (raw)
Tenesa A, Dunlop MG (2009) New insights into the aetiology of colorectal cancer from genome-wide association studies. Nat Rev Genet 10(6):353–358 ArticlePubMedCAS Google Scholar
Feagins LA, Souza RF, Spechler SJ (2009) Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer. Nat Rev Gastroenterol Hepatol 6:297–305 ArticlePubMedCAS Google Scholar
Saleh M, Trinchieri G (2011) Innate immune mechanisms of colitis and colitis-associated colorectal cancer. Nat Rev Immunol 11:9–20 ArticlePubMedCAS Google Scholar
Rubin DC, Shaker A, Levin MS (2012) Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer. Front Immunol 3:107 PubMed Google Scholar
Lakatos PL, Lakatos L (2008) Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies. World J Gastroenterol 14:3937–3947 ArticlePubMed Google Scholar
Eaden JA, Abrams KR, Mayberry JF (2001) The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48:526–535 ArticlePubMedCAS Google Scholar
Canavan C, Abrams KR, Mayberry J (2006) Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther 23:1097–1104 ArticlePubMedCAS Google Scholar
Jess T, Simonsen J, Jorgensen KT, Pedersen BV, Nielsen NM, Frisch M (2012) Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology 143(2):375–381 ArticlePubMed Google Scholar
Herrinton LJ, Liu L, Levin TR, Allison JE, Lewis JD, Velayos F (2012) Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology 143(2):382–389 ArticlePubMed Google Scholar
Nguyen GC, Bressler B (2012) A tale of two cohorts: are we overestimating the risk of colorectal cancer in inflammatory bowel disease? Gastroenterology 143(2):288–290 ArticlePubMed Google Scholar
Rubin DT, Cruz-Correa MR, Gasche C, Jass JR, Lichtenstein GR, Montgomery EA et al (2008) Colorectal cancer prevention in inflammatory bowel disease and the role of 5-aminosalicylic acid: a clinical review and update. Inflamm Bowel Dis 14:265–274 ArticlePubMed Google Scholar
Neumann H, Vieth M, Langner C, Neurath MF, Mudter J (2011) Cancer risk in IBD: how to diagnose and how to manage DALM and ALM. World J Gastroenterol 17:3184–3191 ArticlePubMed Google Scholar
Okayasu I, Ohkusa T, Kajiura K, Kanno J, Sakamoto S (1996) Promotion of colorectal neoplasia in experimental murine ulcerative colitis. Gut 39:87–92 ArticlePubMedCAS Google Scholar
Neufert C, Becker C, Neurath MF (2007) An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Nat Protoc 2:1998–2004 ArticlePubMedCAS Google Scholar
Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140:883–899 ArticlePubMedCAS Google Scholar
Grivennikov SI, Karin M (2010) Inflammation and oncogenesis: a vicious connection. Curr Opin Genet Dev 20:65–71 ArticlePubMedCAS Google Scholar
Trinchieri G (2012) Cancer and inflammation: an old intuition with rapidly evolving new concepts. Annu Rev Immunol 30:677–706 ArticlePubMedCAS Google Scholar
Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759–767 ArticlePubMedCAS Google Scholar
Schneikert J, Behrens J (2007) The canonical Wnt signalling pathway and its APC partner in colon cancer development. Gut 56:417–425 ArticlePubMedCAS Google Scholar
Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW et al (1997) Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC−/− colon carcinoma. Science 275:1784–1787 ArticlePubMedCAS Google Scholar
Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B et al (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275:1787–1790 ArticlePubMedCAS Google Scholar
Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, van den Born M et al (2009) Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457:608–611 ArticlePubMedCAS Google Scholar
Zhu L, Gibson P, Currle DS, Tong Y, Richardson RJ, Bayazitov IT et al (2009) Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 457:603–607 ArticlePubMedCAS Google Scholar
Terzic J, Grivennikov S, Karin E, Karin M (2010) Inflammation and colon cancer. Gastroenterology 138:2101–2114, e2105 ArticlePubMedCAS Google Scholar
Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ et al (2004) IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118:285–296 ArticlePubMedCAS Google Scholar
Ullman TA, Itzkowitz SH (2011) Intestinal inflammation and cancer. Gastroenterology 140:1807–1816 ArticlePubMedCAS Google Scholar
Sturlan S, Oberhuber G, Beinhauer BG, Tichy B, Kappel S, Wang J et al (2001) Interleukin-10-deficient mice and inflammatory bowel disease associated cancer development. Carcinogenesis 22:665–671 ArticlePubMedCAS Google Scholar
Berg DJ, Davidson N, Kuhn R, Muller W, Menon S, Holland G et al (1996) Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Investig 98:1010–1020 ArticlePubMedCAS Google Scholar
Kaler P, Godasi BN, Augenlicht L, Klampfer L (2009) The NF-kappaB/AKT-dependent induction of Wnt signaling in colon cancer cells by macrophages and IL-1beta. Cancer Microenviron 2(1):69–80 Google Scholar
Brown JB, Lee G, Managlia E, Grimm GR, Dirisina R, Goretsky T et al (2010) Mesalamine inhibits epithelial beta-catenin activation in chronic ulcerative colitis. Gastroenterology 138:595–605, 605 e591-593 ArticlePubMedCAS Google Scholar
Lee G, Goretsky T, Managlia E, Dirisina R, Singh AP, Brown JB et al (2010) Phosphoinositide 3-kinase signaling mediates beta-catenin activation in intestinal epithelial stem and progenitor cells in colitis. Gastroenterology 139:869–881, 881 e861-869 ArticlePubMedCAS Google Scholar
Oguma K, Oshima H, Aoki M, Uchio R, Naka K, Nakamura S et al (2008) Activated macrophages promote Wnt signalling through tumour necrosis factor-alpha in gastric tumour cells. EMBO J 27:1671–1681 ArticlePubMedCAS Google Scholar
Tessner TG, Muhale F, Riehl TE, Anant S, Stenson WF (2004) Prostaglandin E2 reduces radiation-induced epithelial apoptosis through a mechanism involving AKT activation and bax translocation. J Clin Invest 114:1676–1685 PubMedCAS Google Scholar
Pozzi A, Yan X, Macias-Perez I, Wei S, Hata AN, Breyer RM et al (2004) Colon carcinoma cell growth is associated with prostaglandin E2/EP4 receptor-evoked ERK activation. J Biol Chem 279:29797–29804 ArticlePubMedCAS Google Scholar
Castellone MD, Teramoto H, Williams BO, Druey KM, Gutkind JS (2005) Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science 310:1504–1510 ArticlePubMedCAS Google Scholar
Westbrook AM, Wei B, Braun J, Schiestl RH (2009) Intestinal mucosal inflammation leads to systemic genotoxicity in mice. Cancer Res 69:4827–4834 ArticlePubMedCAS Google Scholar
Westbrook AM, Schiestl RH (2010) Atm-deficient mice exhibit increased sensitivity to dextran sulfate sodium-induced colitis characterized by elevated DNA damage and persistent immune activation. Cancer Res 70:1875–1884 ArticlePubMedCAS Google Scholar
Meira LB, Bugni JM, Green SL, Lee CW, Pang B, Borenshtein D et al (2008) DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J Clin Invest 118:2516–2525 PubMedCAS Google Scholar
Olipitz W, Wiktor-Brown D, Shuga J, Pang B, McFaline J, Lonkar P et al (2012) Integrated molecular analysis indicates undetectable DNA damage in mice after continuous irradiation at ~400-fold natural background radiation. Environ Health Perspect 120(8):1130–1136 Google Scholar
Mangerich A, Knutson CG, Parry NM, Muthupalani S, Ye W, Prestwich E et al (2012) Infection-induced colitis in mice causes dynamic and tissue-specific changes in stress response and DNA damage leading to colon cancer. Proc Natl Acad Sci U S A 109:E1820–E1829 ArticlePubMed Google Scholar
Kraus S, Arber N (2009) Inflammation and colorectal cancer. Curr Opin Pharmacol 9(4):405–410 ArticlePubMedCAS Google Scholar
Boulard O, Kirchberger S, Royston DJ, Maloy KJ, Powrie FM (2012) Identification of a genetic locus controlling bacteria-driven colitis and associated cancer through effects on innate inflammation. J Exp Med 209:1309–1324 ArticlePubMedCAS Google Scholar
Erdman SE, Rao VP, Poutahidis T, Ihrig MM, Ge Z, Feng Y et al (2003) CD4(+)CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice. Cancer Res 63:6042–6050 PubMedCAS Google Scholar
Erdman SE, Sohn JJ, Rao VP, Nambiar PR, Ge Z, Fox JG et al (2005) CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice. Cancer Res 65:3998–4004 ArticlePubMedCAS Google Scholar
Garrett WS, Punit S, Gallini CA, Michaud M, Zhang D, Sigrist KS et al (2009) Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells. Cancer Cell 16:208–219 ArticlePubMedCAS Google Scholar
Shaked H, Hofseth LJ, Chumanevich A, Chumanevich AA, Wang J, Wang Y et al (2012) Chronic epithelial NF-kappaB activation accelerates APC loss and intestinal tumor initiation through iNOS up-regulation. Proc Natl Acad Sci U S A 109:14007–14012 ArticlePubMedCAS Google Scholar
Erdman SE, Rao VP, Poutahidis T, Rogers AB, Taylor CL, Jackson EA et al (2009) Nitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in _Helicobacter hepaticus_-infected, Rag2-deficient mice. Proc Natl Acad Sci U S A 106:1027–1032 ArticlePubMedCAS Google Scholar
Goodman JE, Hofseth LJ, Hussain SP, Harris CC (2004) Nitric oxide and p53 in cancer-prone chronic inflammation and oxyradical overload disease. Environ Mol Mutagen 44:3–9 ArticlePubMedCAS Google Scholar
Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A (2009) Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30:1073–1081 ArticlePubMedCAS Google Scholar
Vong LB, Tomita T, Yoshitomi T, Matsui H, Nagasaki Y (2012) An orally administered redox nanoparticle that accumlates in the colonic mucosa and reduces colitis in mice. Gastroenterology 143(4):1027–1036.e3 ArticlePubMedCAS Google Scholar
Shimizu T, Marusawa H, Endo Y, Chiba T (2012) Inflammation-mediated genomic instability: roles of activation-induced cytidine deaminase in carcinogenesis. Cancer Sci 103(7):1201–1206 Google Scholar
Takai A, Marusawa H, Minaki Y, Watanabe T, Nakase H, Kinoshita K et al (2012) Targeting activation-induced cytidine deaminase prevents colon cancer development despite persistent colonic inflammation. Oncogene 31:1733–1742 ArticlePubMedCAS Google Scholar
Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz LA Jr, Sjoblom T et al (2006) The colorectal microRNAome. Proc Natl Acad Sci U S A 103:3687–3692 ArticlePubMedCAS Google Scholar
Grady WM, Carethers JM (2008) Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 135:1079–1099 ArticlePubMedCAS Google Scholar
Sabates-Bellver J, Van der Flier LG, de Palo M, Cattaneo E, Maake C, Rehrauer H et al (2007) Transcriptome profile of human colorectal adenomas. Mol Cancer Res 5:1263–1275 ArticlePubMedCAS Google Scholar
Perucho M (2003) Tumors with microsatellite instability: many mutations, targets and paradoxes. Oncogene 22:2223–2225 ArticlePubMedCAS Google Scholar
Foran E, Garrity-Park MM, Mureau C, Newell J, Smyrk TC, Limburg PJ et al (2010) Upregulation of DNA methyltransferase-mediated gene silencing, anchorage-independent growth, and migration of colon cancer cells by interleukin-6. Mol Cancer Res: MCR 8:471–481 ArticlePubMedCAS Google Scholar
Li Y, Deuring J, Peppelenbosch MP, Kuipers EJ, de Haar C, van der Woude CJ (2012) IL-6-induced DNMT1 activity mediates SOCS3 promoter hypermethylation in ulcerative colitis-related colorectal cancer. Carcinogenesis 33(10):1889–1896 Google Scholar
Hartnett L, Egan LJ (2012) Inflammation, DNA methylation and colitis-associated cancer. Carcinogenesis 33:723–731 ArticlePubMedCAS Google Scholar
Hahn MA, Hahn T, Lee DH, Esworthy RS, Kim BW, Riggs AD et al (2008) Methylation of polycomb target genes in intestinal cancer is mediated by inflammation. Cancer Res 68:10280–10289 ArticlePubMedCAS Google Scholar
Eads CA, Nickel AE, Laird PW (2002) Complete genetic suppression of polyp formation and reduction of CpG-island hypermethylation in Apc(Min/+) Dnmt1-hypomorphic mice. Cancer Res 62:1296–1299 PubMedCAS Google Scholar
Yang L, Belaguli N, Berger DH (2009) MicroRNA and colorectal cancer. World J Surg 33:638–646 ArticlePubMed Google Scholar
Boldin MP, Baltimore D (2012) MicroRNAs, new effectors and regulators of NF-kappaB. Immunol Rev 246:205–220 ArticlePubMedCAS Google Scholar
Kanaan Z, Rai SN, Eichenberger MR, Barnes C, Dworkin AM, Weller C et al (2012) Differential microRNA expression tracks neoplastic progression in inflammatory bowel disease-associated colorectal cancer. Hum Mutat 33:551–560 ArticlePubMedCAS Google Scholar
Kuraishy A, Karin M, Grivennikov SI (2011) Tumor promotion via injury- and death-induced inflammation. Immunity 35:467–477 ArticlePubMedCAS Google Scholar
Grivennikov SI, Karin M (2010) Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev 21:11–19 ArticlePubMedCAS Google Scholar
Bollrath J, Phesse TJ, von Burstin VA, Putoczki T, Bennecke M, Bateman T et al (2009) gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell 15:91–102 ArticlePubMedCAS Google Scholar
Grivennikov S, Karin E, Terzic J, Mucida D, Yu GY, Vallabhapurapu S et al (2009) IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15:103–113 ArticlePubMedCAS Google Scholar
Schiechl G, Bauer B, Fuss I, Lang SA, Moser C, Ruemmele P et al (2011) Tumor development in murine ulcerative colitis depends on MyD88 signaling of colonic F4/80+CD11b(high)Gr1(low) macrophages. J Clin Invest 121:1692–1708 ArticlePubMedCAS Google Scholar
Tanaka T, Kohno H, Suzuki R, Hata K, Sugie S, Niho N et al (2006) Dextran sodium sulfate strongly promotes colorectal carcinogenesis in Apc(Min/+) mice: inflammatory stimuli by dextran sodium sulfate results in development of multiple colonic neoplasms. Int J Cancer 118:25–34 ArticlePubMedCAS Google Scholar
Tanaka T, Kohno H, Suzuki R, Yamada Y, Sugie S, Mori H (2003) A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci 94:965–973 ArticlePubMedCAS Google Scholar
Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR et al (2009) A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 15:1016–1022 ArticlePubMedCAS Google Scholar
Gupta RA, Dubois RN (2001) Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 1:11–21 ArticlePubMedCAS Google Scholar
Chung DC (2000) The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis. Gastroenterology 119:854–865 ArticlePubMedCAS Google Scholar
Greten FR, Karin M (2005) NF-κB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5:749–759 ArticlePubMedCAS Google Scholar
Ben-Neriah Y, Karin M (2011) Inflammation meets cancer, with NF-kappaB as the matchmaker. Nat Immunol 12:715–723 ArticlePubMedCAS Google Scholar
Neurath MF, Pettersson S, Meyer zum Buschenfelde KH, Strober W (1996) Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med 2:998–1004 ArticlePubMedCAS Google Scholar
Majumdar S, Aggarwal BB (2001) Methotrexate suppresses NF-kappaB activation through inhibition of IkappaBalpha phosphorylation and degradation. J Immunol 167:2911–2920 PubMedCAS Google Scholar
Karin M (2006) Nuclear factor-kappaB in cancer development and progression. Nature 441:431–436 ArticlePubMedCAS Google Scholar
Eckmann L, Nebelsiek T, Fingerle AA, Dann SM, Mages J, Lang R et al (2008) Opposing functions of IKKbeta during acute and chronic intestinal inflammation. Proc Natl Acad Sci U S A 105:15058–15063 ArticlePubMedCAS Google Scholar
Wang S, Liu Z, Wang L, Zhang X (2009) NF-kappaB signaling pathway, inflammation and colorectal cancer. Cell Mol Immunol 6:327–334 ArticlePubMedCAS Google Scholar
Popivanova BK, Kitamura K, Wu Y, Kondo T, Kagaya T, Kaneko S et al (2008) Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest 118:560–570 PubMedCAS Google Scholar
Kollias G (2004) Modeling the function of tumor necrosis factor in immune pathophysiology. Autoimmun Rev 3(Suppl 1):S24–S25 PubMed Google Scholar
Atreya R, Neurath MF (2008) New therapeutic strategies for treatment of inflammatory bowel disease. Mucosal Immunol 1:175–182 ArticlePubMedCAS Google Scholar
Yu H, Pardoll D, Jove R (2009) STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 9:798–809 ArticlePubMedCAS Google Scholar
Pickert G, Neufert C, Leppkes M, Zheng Y, Wittkopf N, Warntjen M et al (2009) STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med 206:1465–1472 ArticlePubMedCAS Google Scholar
Yang J, Liao X, Agarwal MK, Barnes L, Auron PE, Stark GR (2007) Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB. Genes Dev 21:1396–1408 ArticlePubMedCAS Google Scholar
Lee H, Herrmann A, Deng JH, Kujawski M, Niu G, Li Z et al (2009) Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors. Cancer Cell 15:283–293 ArticlePubMedCAS Google Scholar
Bollrath J, Greten FR (2009) IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis. EMBO Rep 10:1314–1319 ArticlePubMedCAS Google Scholar
Rose-John S, Scheller J, Elson G, Jones SA (2006) Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. J Leukoc Biol 80:227–236 ArticlePubMedCAS Google Scholar
Scheller J, Rose-John S (2006) Interleukin-6 and its receptor: from bench to bedside. Med Microbiol Immunol 195:173–183 ArticlePubMedCAS Google Scholar
Kishimoto T (2005) Interleukin-6: from basic science to medicine—40 years in immunology. Annu Rev Immunol 23:1–21 ArticlePubMedCAS Google Scholar
Atreya R, Mudter J, Finotto S, Mullberg J, Jostock T, Wirtz S et al (2000) Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo. Nat Med 6:583–588 ArticlePubMedCAS Google Scholar
Reinisch W, Gasche C, Tillinger W, Wyatt J, Lichtenberger C, Willheim M et al (1999) Clinical relevance of serum interleukin-6 in Crohn's disease: single point measurements, therapy monitoring, and prediction of clinical relapse. Am J Gastroenterol 94:2156–2164 ArticlePubMedCAS Google Scholar
Ito H, Takazoe M, Fukuda Y, Hibi T, Kusugami K, Andoh A et al (2004) A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease. Gastroenterology 126:989–996, discussion 947 ArticlePubMedCAS Google Scholar
Dominitzki S, Fantini MC, Neufert C, Nikolaev A, Galle PR, Scheller J et al (2007) Cutting edge: trans-signaling via the soluble IL-6R abrogates the induction of FoxP3 in naive CD4+CD25 T cells. J Immunol 179:2041–2045 PubMedCAS Google Scholar
Atreya R, Neurath MF (2008) Signaling molecules: the pathogenic role of the IL-6/STAT-3 trans signaling pathway in intestinal inflammation and in colonic cancer. Curr Drug Targets 9:369–374 ArticlePubMedCAS Google Scholar
Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M et al (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235–238 ArticlePubMedCAS Google Scholar
Becker C, Fantini MC, Wirtz S, Nikolaev A, Lehr HA, Galle PR et al (2005) IL-6 signaling promotes tumor growth in colorectal cancer. Cell Cycle 4:217–220 ArticlePubMedCAS Google Scholar
Becker C, Fantini MC, Schramm C, Lehr HA, Wirtz S, Nikolaev A et al (2004) TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Immunity 21:491–501 ArticlePubMedCAS Google Scholar
Tebbutt NC, Giraud AS, Inglese M, Jenkins B, Waring P, Clay FJ et al (2002) Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat Med 8:1089–1097 ArticlePubMedCAS Google Scholar
Gerlach K, Daniel C, Lehr HA, Nikolaev A, Gerlach T, Atreya R et al (2012) Transcription factor NFATc2 controls the emergence of colon cancer associated with IL-6-dependent colitis. Cancer Res 72(17):4340–4350 ArticlePubMedCAS Google Scholar
Grivennikov SI, Karin M (2011) Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage. Ann Rheum Dis 70(Suppl 1):i104–i108 ArticlePubMedCAS Google Scholar
Putoczki T, Ernst M (2010) More than a sidekick: the IL-6 family cytokine IL-11 links inflammation to cancer. J Leukoc Biol. doi:10.1186/1747-1028-5-14
Waldner MJ, Wirtz S, Jefremow A, Warntjen M, Neufert C, Atreya R et al (2010) VEGF receptor signaling links inflammation and tumorigenesis in colitis-associated cancer. J Exp Med 207:2855–2868 ArticlePubMedCAS Google Scholar
Kullberg MC, Jankovic D, Feng CG, Hue S, Gorelick PL, McKenzie BS et al (2006) IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J Exp Med 203:2485–2494 ArticlePubMedCAS Google Scholar
Buonocore S, Ahern PP, Uhlig HH, Ivanov II, Littman DR, Maloy KJ et al (2010) Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464:1371–1375 ArticlePubMedCAS Google Scholar
Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, McKenzie B et al (2006) IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 116:1310–1316 ArticlePubMedCAS Google Scholar
Cox JH, Kljavin NM, Ota N, Leonard J, Roose-Girma M, Diehl L et al (2012) Opposing consequences of IL-23 signaling mediated by innate and adaptive cells in chemically induced colitis in mice. Mucosal Immunol 5:99–109 ArticlePubMedCAS Google Scholar
Duerr RH (2007) Genome-wide association studies herald a new era of rapid discoveries in inflammatory bowel disease research. Gastroenterology 132:2045–2049 ArticlePubMedCAS Google Scholar
Wirtz S, Neurath MF (2007) Mouse models of inflammatory bowel disease. Adv Drug Deliv Rev 59:1073–1083 ArticlePubMedCAS Google Scholar
Langowski JL, Zhang X, Wu L, Mattson JD, Chen T, Smith K et al (2006) IL-23 promotes tumour incidence and growth. Nature 442:461–465 ArticlePubMedCAS Google Scholar
Langowski JL, Kastelein RA, Oft M (2007) Swords into plowshares: IL-23 repurposes tumor immune surveillance. Trends Immunol 28:207–212 ArticlePubMedCAS Google Scholar
Hinoi T, Akyol A, Theisen BK, Ferguson DO, Greenson JK, Williams BO et al (2007) Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation. Cancer Res 67:9721–9730 ArticlePubMedCAS Google Scholar
Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, Jauch D, Taniguchi K, Yu GY, Österreicher CH, Hung KE, Datz C, Feng Y, Fearon ER, Oukka M, Tessarollo L, Coppola V, Yarovinsky F, Cheroutre H, Eckmann L, Trinchieri G, Karin M (2012) Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature doi:10.1038/nature11465
Hyun YS, Han DS, Lee AR, Eun CS, Youn J, Kim HY (2012) Role of IL-17A in the development of colitis-associated cancer. Carcinogenesis 33:931–936 ArticlePubMedCAS Google Scholar
Chae WJ, Gibson TF, Zelterman D, Hao L, Henegariu O, Bothwell AL (2010) Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis. Proc Natl Acad Sci U S A 107:5540–5544 ArticlePubMedCAS Google Scholar
Yang XO, Chang SH, Park H, Nurieva R, Shah B, Acero L et al (2008) Regulation of inflammatory responses by IL-17F. J Exp Med 205:1063–1075 ArticlePubMedCAS Google Scholar
Chae WJ, Bothwell AL (2011) IL-17F deficiency inhibits small intestinal tumorigenesis in ApcMin/+ mice. Biochem Biophys Res Commun 414:31–36 ArticlePubMedCAS Google Scholar
Tong Z, Yang XO, Yan H, Liu W, Niu X, Shi Y et al (2012) A protective role by interleukin-17F in colon tumorigenesis. PLoS One 7:e34959 ArticlePubMedCAS Google Scholar
Leppkes M, Becker C, Ivanov II, Hirth S, Wirtz S, Neufert C et al (2009) RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. Gastroenterology 136:257–267 ArticlePubMedCAS Google Scholar
Kesselring R, Jauch D, Fichtner-Feigl S (2012) Interleukin 21 impairs tumor immunosurveillance of colitis-associated colorectal cancer. Oncoimmunology 1:537–538 ArticlePubMed Google Scholar
Stolfi C, Rizzo A, Franze E, Rotondi A, Fantini MC, Sarra M et al (2011) Involvement of interleukin-21 in the regulation of colitis-associated colon cancer. J Exp Med 208:2279–2290 ArticlePubMedCAS Google Scholar
Jauch D, Martin M, Schiechl G, Kesselring R, Schlitt HJ, Geissler EK et al (2011) Interleukin 21 controls tumour growth and tumour immunosurveillance in colitis-associated tumorigenesis in mice. Gut 60:1678–1686 ArticlePubMedCAS Google Scholar
Rakoff-Nahoum S, Medzhitov R (2007) Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 317:124–127 ArticlePubMedCAS Google Scholar
Rakoff-Nahoum S, Medzhitov R (2008) Role of toll-like receptors in tissue repair and tumorigenesis. Biochemistry (Mosc) 73:555–561 ArticleCAS Google Scholar
Salcedo R, Worschech A, Cardone M, Jones Y, Gyulai Z, Dai RM et al (2010) MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18. J Exp Med 207:1625–1636 ArticlePubMedCAS Google Scholar
Normand S, Delanoye-Crespin A, Bressenot A, Huot L, Grandjean T, Peyrin-Biroulet L et al (2011) Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury. Proc Natl Acad Sci U S A 108:9601–9606 ArticlePubMedCAS Google Scholar
Allen IC, TeKippe EM, Woodford RM, Uronis JM, Holl EK, Rogers AB et al (2010) The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med 207:1045–1056 ArticlePubMedCAS Google Scholar
Allen IC, Wilson JE, Schneider M, Lich JD, Roberts RA, Arthur JC et al (2012) NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-kappaB signaling. Immunity 36:742–754 ArticlePubMedCAS Google Scholar
Wan YY, Flavell RA (2008) TGF-beta and regulatory T cell in immunity and autoimmunity. J Clin Immunol 28:647–659 ArticlePubMedCAS Google Scholar
Uronis JM, Muhlbauer M, Herfarth HH, Rubinas TC, Jones GS, Jobin C (2009) Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS One 4:e6026 ArticlePubMedCAS Google Scholar
Fantini MC, Rizzo A, Fina D, Caruso R, Sarra M, Stolfi C et al (2009) Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression. Gastroenterology 136(1308–1316):e1301–e1303 Google Scholar
Rizzo A, Waldner MJ, Stolfi C, Sarra M, Fina D, Becker C et al (2011) Smad7 expression in T cells prevents colitis-associated cancer. Cancer Res 71:7423–7432 ArticlePubMedCAS Google Scholar
Dube PE, Yan F, Punit S, Girish N, McElroy SJ, Washington MK et al (2012) Epidermal growth factor receptor inhibits colitis-associated cancer in mice. J Clin Invest 122(8):2780–2792 ArticlePubMedCAS Google Scholar
Cohen DJ, Hochster HS (2008) Rationale for combining biotherapy in the treatment of advanced colon cancer. Gastrointest Cancer Res 2:145–151 PubMed Google Scholar
Sartor RB (2008) Microbial influences in inflammatory bowel diseases. Gastroenterology 134:577–594 ArticlePubMedCAS Google Scholar
Blaser MJ (2010) Harnessing the power of the human microbiome. Proc Natl Acad Sci U S A 107:6125–6126 ArticlePubMedCAS Google Scholar
Othman M, Aguero R, Lin HC (2008) Alterations in intestinal microbial flora and human disease. Curr Opin Gastroenterol 24:11–16 ArticlePubMed Google Scholar
Guarner F, Malagelada JR (2003) Gut flora in health and disease. Lancet 361:512–519 ArticlePubMed Google Scholar
Rowland IR (2009) The role of the gastrointestinal microbiota in colorectal cancer. Curr Pharm Des 15:1524–1527 ArticlePubMedCAS Google Scholar
Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D et al (2009) Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461:1282–1286 ArticlePubMedCAS Google Scholar
Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS et al (2006) Metagenomic analysis of the human distal gut microbiome. Science 312:1355–1359 ArticlePubMedCAS Google Scholar
Cho I, Blaser MJ (2012) The human microbiome: at the interface of health and disease. Nat Rev Genet 13:260–270 PubMedCAS Google Scholar
Li Y, Kundu P, Seow SW, de Matos CT, Aronsson L, Chin KC et al (2012) Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APCMin/+ mice. Carcinogenesis 33:1231–1238 ArticlePubMedCAS Google Scholar
Dove WF, Clipson L, Gould KA, Luongo C, Marshall DJ, Moser AR et al (1997) Intestinal neoplasia in the ApcMin mouse: independence from the microbial and natural killer (beige locus) status. Cancer Res 57:812–814 PubMedCAS Google Scholar
Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U et al (2009) Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139:485–498 ArticlePubMedCAS Google Scholar
Ivanov II, Frutos Rde L, Manel N, Yoshinaga K, Rifkin DB, Sartor RB et al (2008) Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4:337–349 ArticlePubMedCAS Google Scholar
Kim SC, Tonkonogy SL, Karrasch T, Jobin C, Sartor RB (2007) Dual-association of gnotobiotic IL-10−/− mice with 2 nonpathogenic commensal bacteria induces aggressive pancolitis. Inflamm Bowel Dis 13:1457–1466 ArticlePubMed Google Scholar
Kullberg MC, Ward JM, Gorelick PL, Caspar P, Hieny S, Cheever A et al (1998) Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect Immun 66:5157–5166 PubMedCAS Google Scholar
Mazmanian SK, Round JL, Kasper DL (2008) A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453:620–625 ArticlePubMedCAS Google Scholar
Round JL, Mazmanian SK (2009) The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9:313–323 ArticlePubMedCAS Google Scholar
Round JL, O'Connell RM, Mazmanian SK (2010) Coordination of tolerogenic immune responses by the commensal microbiota. J Autoimmun 34:J220–J225 ArticlePubMedCAS Google Scholar
Arthur JC, Jobin C (2011) The struggle within: microbial influences on colorectal cancer. Inflamm Bowel Dis 17:396–409 ArticlePubMed Google Scholar
Strober W, Fuss IJ (2006) Experimental models of mucosal inflammation. Adv Exp Med Biol 579:55–97 ArticlePubMedCAS Google Scholar
Kolida S, Gibson GR (2011) Synbiotics in health and disease. Annu Rev Food Sci Technol 2:373–393 ArticlePubMed Google Scholar
Chichlowski M, Sharp JM, Vanderford DA, Myles MH, Hale LP (2008) Helicobacter typhlonius and Helicobacter rodentium differentially affect the severity of colon inflammation and inflammation-associated neoplasia in IL10-deficient mice. Comp Med 58:534–541 PubMedCAS Google Scholar
Newman JV, Kosaka T, Sheppard BJ, Fox JG, Schauer DB (2001) Bacterial infection promotes colon tumorigenesis in Apc(Min/+) mice. J Infect Dis 184:227–230 ArticlePubMedCAS Google Scholar
Issa M, Vijayapal A, Graham MB, Beaulieu DB, Otterson MF, Lundeen S et al (2007) Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol 5:345–351 ArticlePubMed Google Scholar
Strober W, Fuss I, Mannon P (2007) The fundamental basis of inflammatory bowel disease. J Clin Invest 117:514–521 ArticlePubMedCAS Google Scholar
Iliev ID, Funari VA, Taylor KD, Nguyen Q, Reyes CN, Strom SP et al (2012) Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science 336:1314–1317 ArticlePubMedCAS Google Scholar
Johansson ME, Phillipson M, Petersson J, Velcich A, Holm L, Hansson GC (2008) The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci U S A 105:15064–15069 ArticlePubMedCAS Google Scholar
Petersson J, Schreiber O, Hansson GC, Gendler SJ, Velcich A, Lundberg JO et al (2011) Importance and regulation of the colonic mucus barrier in a mouse model of colitis. Am J Physiol Gastrointest Liver Physiol 300:G327–G333 ArticlePubMedCAS Google Scholar
Van der Sluis M, De Koning BA, De Bruijn AC, Velcich A, Meijerink JP, Van Goudoever JB et al (2006) Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 131:117–129 ArticlePubMedCAS Google Scholar
Velcich A, Yang W, Heyer J, Fragale A, Nicholas C, Viani S et al (2002) Colorectal cancer in mice genetically deficient in the mucin Muc2. Science 295:1726–1729 ArticlePubMedCAS Google Scholar
Yang K, Popova NV, Yang WC, Lozonschi I, Tadesse S, Kent S et al (2008) Interaction of Muc2 and Apc on Wnt signaling and in intestinal tumorigenesis: potential role of chronic inflammation. Cancer Res 68:7313–7322 ArticlePubMedCAS Google Scholar
Khounlotham M, Kim W, Peatman E, Nava P, Medina-Contreras O, Addis C (2012) Compromised intestinal epithelial barrier induces adaptive immune compensation that protects from colitis. Immunity 37(3):563–573 ArticlePubMedCAS Google Scholar
Iacucci M, Ghosh S (2011) Looking beyond symptom relief: evolution of mucosal healing in inflammatory bowel disease. Therap Adv Gastroenterol 4:129–143 ArticlePubMed Google Scholar
Kiesslich R, Goetz M, Angus EM, Hu Q, Guan Y, Potten C et al (2007) Identification of epithelial gaps in human small and large intestine by confocal endomicroscopy. Gastroenterology 133:1769–1778 ArticlePubMed Google Scholar
Kiesslich R, Duckworth CA, Moussata D, Gloeckner A, Lim LG, Goetz M et al (2012) Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease. Gut 61:1146–1153 ArticlePubMedCAS Google Scholar
Sonnenberg GF, Monticelli LA, Alenghat T, Fung TC, Hutnick NA, Kunisawa J et al (2012) Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 336:1321–1325 ArticlePubMedCAS Google Scholar
Fouts DE, Torralba M, Nelson KE, Brenner DA, Schnabl B (2012) Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease. J Hepatol 56:1283–1292 ArticlePubMedCAS Google Scholar
Seki E, Schnabl B (2012) Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut. J Physiol 590:447–458 ArticlePubMedCAS Google Scholar
Yan AW, Schnabl B (2012) Bacterial translocation and changes in the intestinal microbiome associated with alcoholic liver disease. World J Hepatol 4:110–118 ArticlePubMed Google Scholar
Arthur JC, Perez-Chanona E, Muhlbauer M, Tomkovich S, Uronis JM, Fan TJ et al (2012) Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338(6103):120–123 Google Scholar
Scanlan PD, Shanahan F, Clune Y, Collins JK, O'Sullivan GC, O'Riordan M et al (2008) Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environ Microbiol 10:789–798 ArticlePubMedCAS Google Scholar
Nanau RM, Neuman MG (2012) Metabolome and inflammasome in inflammatory bowel disease. Transl Res 160:1–28 ArticlePubMedCAS Google Scholar
Neuman MG, Nanau RM (2012) Inflammatory bowel disease: role of diet, microbiota, life style. Transl Res 160:29–44 ArticlePubMed Google Scholar
Blumberg R, Powrie F (2012) Microbiota, disease, and back to health: a metastable journey. Sci Transl Med 4:137rv137 ArticleCAS Google Scholar
Garrett WS, Gallini CA, Yatsunenko T, Michaud M, DuBois A, Delaney ML et al (2010) Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 8:292–300 ArticlePubMedCAS Google Scholar
Garrett WS, Lord GM, Punit S, Lugo-Villarino G, Mazmanian SK, Ito S et al (2007) Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 131:33–45 ArticlePubMedCAS Google Scholar
Vijay-Kumar M, Sanders CJ, Taylor RT, Kumar A, Aitken JD, Sitaraman SV et al (2007) Deletion of TLR5 results in spontaneous colitis in mice. J Clin Invest 117:3909–3921 PubMedCAS Google Scholar
Chamaillard M, Dessein R (2011) Defensins couple dysbiosis to primary immunodeficiency in Crohn's disease. World J Gastroenterol 17:567–571 ArticlePubMed Google Scholar
Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T et al (2012) Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482:179–185 PubMedCAS Google Scholar
Elinav E, Strowig T, Kau AL, Henao-Mejia J, Thaiss CA, Booth CJ et al (2011) NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145:745–757 ArticlePubMedCAS Google Scholar
Hu B, Elinav E, Flavell RA (2011) Inflammasome-mediated suppression of inflammation-induced colorectal cancer progression is mediated by direct regulation of epithelial cell proliferation. Cell Cycle 10:1936–1939 ArticlePubMedCAS Google Scholar
Hu B, Elinav E, Huber S, Booth CJ, Strowig T, Jin C et al (2010) Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4. Proc Natl Acad Sci U S A 107:21635–21640 ArticlePubMed Google Scholar
Chen GY, Shaw MH, Redondo G, Nunez G (2008) The innate immune receptor Nod1 protects the intestine from inflammation-induced tumorigenesis. Cancer Res 68:10060–10067 ArticlePubMedCAS Google Scholar
Ayres JS, Trinidad NJ, Vance RE (2012) Lethal inflammasome activation by a multidrug-resistant pathobiont upon antibiotic disruption of the microbiota. Nat Med 18:799–806 ArticlePubMedCAS Google Scholar
Zakostelska Z, Kverka M, Klimesova K, Rossmann P, Mrazek J, Kopecny J et al (2011) Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironment. PLoS One 6:e27961 ArticlePubMedCAS Google Scholar
Tlaskalova-Hogenova H, Stepankova R, Kozakova H, Hudcovic T, Vannucci L, Tuckova L et al (2011) The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol Immunol 8:110–120 ArticlePubMedCAS Google Scholar
Kverka M, Zakostelska Z, Klimesova K, Sokol D, Hudcovic T, Hrncir T et al (2011) Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition. Clin Exp Immunol 163:250–259 ArticlePubMedCAS Google Scholar
Appleyard CB, Cruz ML, Isidro AA, Arthur JC, Jobin C, De Simone C (2011) Pretreatment with the probiotic VSL#3 delays transition from inflammation to dysplasia in a rat model of colitis-associated cancer. Am J Physiol Gastrointest Liver Physiol 301:G1004–G1013 ArticlePubMedCAS Google Scholar
Uronis JM, Arthur JC, Keku T, Fodor A, Carroll IM, Cruz ML et al (2011) Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitis. Inflamm Bowel Dis 17:289–297 ArticlePubMed Google Scholar
Weissman JS, Coyle W (2012) Stool transplants: ready for prime time? Curr Gastroenterol Rep 14(4):313–316 Google Scholar
El-Matary W, Simpson R, Ricketts-Burns N (2012) Fecal microbiota transplantation: are we opening a can of worms? Gastroenterology 143(2):e19 ArticlePubMed Google Scholar
Brandt LJ (2012) Fecal transplantation for the treatment of Clostridium difficile infection. Gastroenterol Hepatol (N Y) 8:191–194 Google Scholar
Holmes E, Kinross J, Gibson GR, Burcelin R, Jia W, Pettersson S et al (2012) Therapeutic modulation of microbiota-host metabolic interactions. Sci Transl Med 4:137rv136 ArticleCAS Google Scholar
Rabizadeh S, Rhee KJ, Wu S, Huso D, Gan CM, Golub JE et al (2007) Enterotoxigenic bacteroides fragilis: a potential instigator of colitis. Inflamm Bowel Dis 13:1475–1483 ArticlePubMed Google Scholar
Huycke MM, Abrams V, Moore DR (2002) Enterococcus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial cell DNA. Carcinogenesis 23:529–536 ArticlePubMedCAS Google Scholar
Strauss J, Kaplan GG, Beck PL, Rioux K, Panaccione R, Devinney R et al (2011) Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm Bowel Dis 17:1971–1978 ArticlePubMed Google Scholar
Strauss J, Kaplan GG, Beck PL, Rioux K, Panaccione R, Devinney R et al (2011) Invasive potential of gut mucosa-derived fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm Bowel Dis 17(9):1971–1978 ArticlePubMed Google Scholar
Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM et al (2012) Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res 22:292–298 ArticlePubMedCAS Google Scholar
Yang L, Pei Z (2006) Bacteria, inflammation, and colon cancer. World J Gastroenterol 12:6741–6746 PubMedCAS Google Scholar
Sears CL, Pardoll DM (2011) Perspective: alpha-bugs, their microbial partners, and the link to colon cancer. J Infect Dis 203:306–311 ArticlePubMed Google Scholar
Klampfer L (2008) The role of signal transducers and activators of transcription in colon cancer. Front Biosci 13:2888–2899 ArticlePubMedCAS Google Scholar
Wu Y, Zhou BP (2009) Inflammation: a driving force speeds cancer metastasis. Cell Cycle 8(20):3267–3273 ArticlePubMedCAS Google Scholar
Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119:1420–1428 ArticlePubMedCAS Google Scholar
Yang J, Weinberg RA (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14:818–829 ArticlePubMedCAS Google Scholar
Wu Y, Deng J, Rychahou PG, Qiu S, Evers BM, Zhou BP (2009) Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell 15:416–428 ArticlePubMedCAS Google Scholar
Voronov E, Shouval DS, Krelin Y, Cagnano E, Benharroch D, Iwakura Y et al (2003) IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci U S A 100:2645–2650 ArticlePubMedCAS Google Scholar
Luo JL, Maeda S, Hsu LC, Yagita H, Karin M (2004) Inhibition of NF-kappaB in cancer cells converts inflammation-induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. Cancer Cell 6:297–305 ArticlePubMedCAS Google Scholar
Bonecchi R, Galliera E, Borroni EM, Corsi MM, Locati M, Mantovani A (2009) Chemokines and chemokine receptors: an overview. Front Biosci 14:540–551 ArticlePubMedCAS Google Scholar
Wolf MJ, Hoos A, Bauer J, Boettcher S, Knust M, Weber A et al (2012) Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway. Cancer Cell 22:91–105 ArticlePubMedCAS Google Scholar
Zucker S, Vacirca J (2004) Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev 23:101–117 ArticlePubMedCAS Google Scholar
Mohammed FF, Smookler DS, Taylor SE, Fingleton B, Kassiri Z, Sanchez OH et al (2004) Abnormal TNF activity in Timp3−/− mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat Genet 36:969–977 ArticlePubMedCAS Google Scholar
Luo JL, Tan W, Ricono JM, Korchynskyi O, Zhang M, Gonias SL et al (2007) Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin. Nature 446:690–694 ArticlePubMedCAS Google Scholar